Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	Ig_I-set	CHL1 IGFN1 LRIT3 PXDN HMCN2 CNTN1 CNTN4 OBSL1 LINGO2 ICAM5 WFIKKN2 MYBPC2	9.02e-07	190	198	12	IPR013098
Domain	I-set	CHL1 IGFN1 LRIT3 PXDN HMCN2 CNTN1 CNTN4 OBSL1 LINGO2 ICAM5 WFIKKN2 MYBPC2	9.02e-07	190	198	12	PF07679
Domain	IGc2	CHL1 IGFN1 LRIT3 PXDN HMCN2 KIT CNTN1 CNTN4 OBSL1 LINGO2 ICAM5 WFIKKN2 MYBPC2	1.41e-06	235	198	13	SM00408
Domain	Ig_sub2	CHL1 IGFN1 LRIT3 PXDN HMCN2 KIT CNTN1 CNTN4 OBSL1 LINGO2 ICAM5 WFIKKN2 MYBPC2	1.41e-06	235	198	13	IPR003598
Domain	IG	CHL1 IGFN1 LRIT3 BTN2A2 PXDN HMCN2 KIT CNTN1 CNTN4 LAG3 OBSL1 LINGO2 ICAM5 BTNL2 WFIKKN2 MYBPC2	1.13e-05	421	198	16	SM00409
Domain	Ig_sub	CHL1 IGFN1 LRIT3 BTN2A2 PXDN HMCN2 KIT CNTN1 CNTN4 LAG3 OBSL1 LINGO2 ICAM5 BTNL2 WFIKKN2 MYBPC2	1.13e-05	421	198	16	IPR003599
Domain	IG_LIKE	CHL1 IGFN1 LRIT3 BTN2A2 PXDN HMCN2 KIT CNTN1 CNTN4 LAG3 OBSL1 LINGO2 ICAM5 BTNL2 WFIKKN2 MYBPC2	7.24e-05	491	198	16	PS50835
Domain	Ig-like_dom	CHL1 IGFN1 LRIT3 BTN2A2 PXDN HMCN2 KIT CNTN1 CNTN4 LAG3 OBSL1 LINGO2 ICAM5 BTNL2 WFIKKN2 MYBPC2	9.59e-05	503	198	16	IPR007110
Domain	GPCR_2_VIP_rcpt	VIPR1 VIPR2	1.12e-04	2	198	2	IPR001571
Domain	Acetyltransf_13	ESCO1 ESCO2	1.12e-04	2	198	2	PF13880
Domain	zf-C2H2_3	ESCO1 ESCO2	1.12e-04	2	198	2	PF13878
Domain	ESCO_Acetyltransf_dom	ESCO1 ESCO2	1.12e-04	2	198	2	IPR028009
Domain	AcTrfase_ESCO_Znf_dom	ESCO1 ESCO2	1.12e-04	2	198	2	IPR028005
Domain	HormR	ADGRB1 VIPR1 VIPR2 CELSR3	1.30e-04	25	198	4	SM00008
Domain	HRM	ADGRB1 VIPR1 VIPR2 CELSR3	2.06e-04	28	198	4	PF02793
Domain	Sushi	CFHR5 SVEP1 CR2 SEZ6L2 CSMD1	2.21e-04	52	198	5	PF00084
Domain	Mab-21	MIEF1 MIEF2 MAB21L3	2.41e-04	12	198	3	PF03281
Domain	Mab-21	MIEF1 MIEF2 MAB21L3	2.41e-04	12	198	3	SM01265
Domain	Mab-21_dom	MIEF1 MIEF2 MAB21L3	2.41e-04	12	198	3	IPR024810
Domain	CCP	CFHR5 SVEP1 CR2 SEZ6L2 CSMD1	2.64e-04	54	198	5	SM00032
Domain	SUSHI	CFHR5 SVEP1 CR2 SEZ6L2 CSMD1	3.14e-04	56	198	5	PS50923
Domain	Stereocilin-rel	STRC MSLN	3.33e-04	3	198	2	IPR026664
Domain	Sushi_SCR_CCP_dom	CFHR5 SVEP1 CR2 SEZ6L2 CSMD1	3.41e-04	57	198	5	IPR000436
Domain	ConA-like_dom	CLSTN3 MEFV SVEP1 COL24A1 BTN2A2 FAT4 TRIM58 TSPEAR CELSR3	5.63e-04	219	198	9	IPR013320
Domain	Glyco_hydro_1_N_CS	KL LCTL	6.62e-04	4	198	2	IPR033132
Domain	Glyco_hydro_1_AS	KL LCTL	6.62e-04	4	198	2	IPR018120
Domain	GPCR_2_extracellular_dom	ADGRB1 VIPR1 VIPR2 CELSR3	8.31e-04	40	198	4	IPR001879
Domain	G_PROTEIN_RECEP_F2_1	ADGRB1 VIPR1 VIPR2 CELSR3	8.31e-04	40	198	4	PS00649
Domain	G_PROTEIN_RECEP_F2_3	ADGRB1 VIPR1 VIPR2 CELSR3	8.31e-04	40	198	4	PS50227
Domain	GLYCOSYL_HYDROL_F1_1	KL LCTL	1.09e-03	5	198	2	PS00572
Domain	Glyco_hydro_1	KL LCTL	1.09e-03	5	198	2	PF00232
Domain	GLYCOSYL_HYDROL_F1_2	KL LCTL	1.09e-03	5	198	2	PS00653
Domain	Glyco_hydro_1	KL LCTL	1.09e-03	5	198	2	IPR001360
Domain	FN3	CHL1 IGFN1 LRIT3 CNTN1 CNTN4 OBSL1 IL9R MYBPC2	1.31e-03	199	198	8	PS50853
Pubmed	Characterization and comparison of four serine- and arginine-rich (SR) protein kinases.	CLK4 CLK1 CLK3	8.89e-07	4	212	3	9307018
Pubmed	Cdc2-like kinases and DNA topoisomerase I regulate alternative splicing of tissue factor in human endothelial cells.	CLK4 CLK1 CLK3	2.21e-06	5	212	3	19168442
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	EPPK1 KIF26A SHISA5 KDM6B STK11IP TBC1D16 JAK3 KMT2C TAGLN GCN1 CRYBG2 UBR4 ZDHHC7 SCAP DNAJC14 CELSR3 RPAP1 SNAPC4 TOP3A PCNT HR	4.65e-06	1105	212	21	35748872
Pubmed	Expression of the immunoglobulin superfamily cell adhesion molecules in the developing spinal cord and dorsal root ganglion.	CHL1 LRIT3 PXDN CNTN1 CNTN4 OBSL1 LINGO2 ICAM5	7.38e-06	162	212	8	25826454
Pubmed	Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.	SPART LENG8 ANAPC1 TSEN34 POLD1 OBSL1 APC AP3B1 NBR1	1.94e-05	242	212	9	34011540
Pubmed	Organization and complete sequence of identical embryonic and plasmacytoma kappa V-region genes.	IGKV1D-13 IGKV1-13 IGKV1-9	3.55e-05	11	212	3	6767723
Pubmed	Amino acid sequence of the variable region of M149 mouse myeloma light chain: comparison with the nucleotide sequence of K2 and K3 clones.	IGKV1D-13 IGKV1-13 IGKV1-9	3.55e-05	11	212	3	6795447
Pubmed	Multiple related immunoglobulin variable-region genes identified by cloning and sequence analysis.	IGKV1D-13 IGKV1-13 IGKV1-9	3.55e-05	11	212	3	279004
Pubmed	Altered expression of vasoactive intestinal peptide receptors in T lymphocytes and aberrant Th1 immunity in multiple sclerosis.	VIPR1 VIPR2	3.70e-05	2	212	2	17077178
Pubmed	Parkin deficiency perturbs striatal circuit dynamics.	RET PRKN	3.70e-05	2	212	2	31923460
Pubmed	Differential effects of β-catenin and NF-κB interplay in the regulation of cell proliferation, inflammation and tumorigenesis in response to bacterial infection.	APC TLR4	3.70e-05	2	212	2	24278135
Pubmed	Lack of Parkin Anticipates the Phenotype and Affects Mitochondrial Morphology and mtDNA Levels in a Mouse Model of Parkinson's Disease.	SLC6A3 PRKN	3.70e-05	2	212	2	29222404
Pubmed	A protective role of mast cells in intestinal tumorigenesis.	KIT APC	3.70e-05	2	212	2	18258601
Pubmed	An epigenetic increase in mitochondrial fission by MiD49 and MiD51 regulates the cell cycle in cancer: Diagnostic and therapeutic implications.	MIEF1 MIEF2	3.70e-05	2	212	2	32068312
Pubmed	Expression of pituitary adenylate cyclase-activating polypeptide 1 and 2 receptor mRNA in gallbladder tissue of patients with gallstone or gallbladder polyps.	VIPR1 VIPR2	3.70e-05	2	212	2	16552823
Pubmed	Radical reversal of vasoactive intestinal peptide (VIP) receptors during early lymphopoiesis.	VIPR1 VIPR2	3.70e-05	2	212	2	21878358
Pubmed	Two human orthologues of Eco1/Ctf7 acetyltransferases are both required for proper sister-chromatid cohesion.	ESCO1 ESCO2	3.70e-05	2	212	2	15958495
Pubmed	Microarray based analysis of an inherited terminal 3p26.3 deletion, containing only the CHL1 gene, from a normal father to his two affected children.	CHL1 CNTN4	3.70e-05	2	212	2	21457564
Pubmed	Identification and characterization of five-transmembrane isoforms of human vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors.	VIPR1 VIPR2	3.70e-05	2	212	2	16934434
Pubmed	LXXLL motifs and AF-2 domain mediate SHP (NR0B2) homodimerization and DAX1 (NR0B1)-DAX1A heterodimerization.	NR0B1 NR0B2	3.70e-05	2	212	2	17686645
Pubmed	New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway.	PCSK9 TLR4	3.70e-05	2	212	2	28535426
Pubmed	The first intestinal motility patterns in fetal mice are not mediated by neurons or interstitial cells of Cajal.	KIT RET	3.70e-05	2	212	2	20142273
Pubmed	Effect of positive charge in VIP 16gamma-glutamyl diamino derivatives on hVPAC1 and hVPAC2 receptor function.	VIPR1 VIPR2	3.70e-05	2	212	2	17883247
Pubmed	Functional intestinal stem cells after Paneth cell ablation induced by the loss of transcription factor Math1 (Atoh1).	APC ATOH1	3.70e-05	2	212	2	22586121
Pubmed	Compromised NMDA/Glutamate Receptor Expression in Dopaminergic Neurons Impairs Instrumental Learning, But Not Pavlovian Goal Tracking or Sign Tracking.	GRIN1 SLC6A3	3.70e-05	2	212	2	26464985
Pubmed	Conditional knockout of NMDA receptors in dopamine neurons prevents nicotine-conditioned place preference.	GRIN1 SLC6A3	3.70e-05	2	212	2	20062537
Pubmed	L-DOPA impairs proteasome activity in parkinsonism through D1 dopamine receptor.	SLC6A3 PRKN	3.70e-05	2	212	2	22238104
Pubmed	Expression of vasoactive intestinal peptide (VIP) receptors in human uterus.	VIPR1 VIPR2	3.70e-05	2	212	2	11072126
Pubmed	Possible regulation of Toll-like receptor 4 by lysine acetylation through LPCAT2 activity in RAW264.7 cells.	LPCAT2 TLR4	3.70e-05	2	212	2	35735109
Pubmed	Wnt-induced, TRP53-mediated Cell Cycle Arrest of Precursors Underlies Interstitial Cell of Cajal Depletion During Aging.	KL APC	3.70e-05	2	212	2	32771388
Pubmed	Terminal 3p deletions in two families--correlation between molecular karyotype and phenotype.	CHL1 CNTN4	3.70e-05	2	212	2	20101686
Pubmed	Constitutive TLR4 signalling in intestinal epithelium reduces tumor load by increasing apoptosis in APC(Min/+) mice.	APC TLR4	3.70e-05	2	212	2	23318418
Pubmed	VPAC1 and VPAC2 receptor deficiencies negatively influence pregnancy outcome through distinct and overlapping modulations of immune, trophoblast and vascular functions.	VIPR1 VIPR2	3.70e-05	2	212	2	36328148
Pubmed	NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension.	TAGLN GRIN1	3.70e-05	2	212	2	29444988
Pubmed	Hepatocyte growth factor enhances alternative splicing of the Kruppel-like factor 6 (KLF6) tumor suppressor to promote growth through SRSF1.	HGF KLF6	3.70e-05	2	212	2	22859706
Pubmed	The immunohistochemical profile of granular cell (Abrikossoff) tumor suggests an endomesenchymal origin.	KIT RET	3.70e-05	2	212	2	25262119
Pubmed	Neutrophils activate macrophages for intracellular killing of Leishmania major through recruitment of TLR4 by neutrophil elastase.	TLR4 ELANE	3.70e-05	2	212	2	17785837
Pubmed	Selective gene expression and activation-dependent regulation of vasoactive intestinal peptide receptor type 1 and type 2 in human T cells.	VIPR1 VIPR2	3.70e-05	2	212	2	11160313
Pubmed	Increase in histamine synthesis by liver macrophages in CCl4-injured mast cell-deficient W/Wv mice.	KIT TLR4	3.70e-05	2	212	2	8765479
Pubmed	RET signaling does not modulate MPTP toxicity but is required for regeneration of dopaminergic axon terminals.	RET SLC6A3	3.70e-05	2	212	2	18056810
Pubmed	Role of Janus kinase 3 in mast cell-mediated innate immunity against gram-negative bacteria.	JAK3 KIT	3.70e-05	2	212	2	11520465
Pubmed	PARK2 deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in Apc mutant mice.	APC PRKN	3.70e-05	2	212	2	20696900
Pubmed	Parkin increases dopamine uptake by enhancing the cell surface expression of dopamine transporter.	SLC6A3 PRKN	3.70e-05	2	212	2	15492001
Pubmed	Parkin ubiquitinates phosphoglycerate dehydrogenase to suppress serine synthesis and tumor progression.	PHGDH PRKN	3.70e-05	2	212	2	32478681
Pubmed	Regulation of alternative splicing of human tau exon 10 by phosphorylation of splicing factors.	CLK4 CLK1	3.70e-05	2	212	2	11461155
Pubmed	Alterations of vasoactive intestinal polypeptide receptors in allergic rhinitis.	VIPR1 VIPR2	3.70e-05	2	212	2	21711977
Pubmed	Relief from neuropathic pain by blocking of the platelet-activating factor-pain loop.	LPCAT2 ICAM5	3.70e-05	2	212	2	28341636
Pubmed	Gene expression of vasoactive intestinal peptide receptors in human lung cancer.	VIPR1 VIPR2	3.70e-05	2	212	2	21769421
Pubmed	Hereditary paraganglioma-pheochromocytoma syndromes associated with SDHD and RET mutations.	SDHD RET	3.70e-05	2	212	2	24375508
Pubmed	The mitochondrial elongation factors MIEF1 and MIEF2 exert partially distinct functions in mitochondrial dynamics.	MIEF1 MIEF2	3.70e-05	2	212	2	23880462
Pubmed	Myocyte TLR4 enhances enteric and systemic inflammation driving late murine endotoxic ileus.	TAGLN TLR4	3.70e-05	2	212	2	25747352
Pubmed	Esco1 and Esco2 regulate distinct cohesin functions during cell cycle progression.	ESCO1 ESCO2	3.70e-05	2	212	2	28847955
Pubmed	Activation of Th lymphocytes alters pattern expression and cellular location of VIP receptors in healthy donors and early arthritis patients.	VIPR1 VIPR2	3.70e-05	2	212	2	31089161
Pubmed	The ret oncogene can induce melanogenesis and melanocyte development in Wv/Wv mice.	KIT RET	3.70e-05	2	212	2	1374037
Pubmed	The neurotransmitter VIP expands the pool of symmetrically dividing postnatal dentate gyrus precursors via VPAC2 receptors or directs them toward a neuronal fate via VPAC1 receptors.	VIPR1 VIPR2	3.70e-05	2	212	2	19650041
Pubmed	Analysis of ER-mitochondria contacts using correlative fluorescence microscopy and soft X-ray tomography of mammalian cells.	MIEF1 MIEF2	3.70e-05	2	212	2	26101352
Pubmed	A genetic link between discriminative fear coding by the lateral amygdala, dopamine, and fear generalization.	GRIN1 SLC6A3	3.70e-05	2	212	2	26402461
Pubmed	Differential expression of vasoactive intestinal peptide receptors 1 and 2 (VIP-R1 and VIP-R2) mRNA in murine lymphocytes.	VIPR1 VIPR2	3.70e-05	2	212	2	8784257
Pubmed	Neutrophil elastase modulates cytokine expression: contribution to host defense against Pseudomonas aeruginosa-induced pneumonia.	TLR4 ELANE	3.70e-05	2	212	2	22927440
Pubmed	Atonal homolog 1 is a tumor suppressor gene.	APC ATOH1	3.70e-05	2	212	2	19243219
Pubmed	Neutrophil elastase promotes neointimal hyperplasia by targeting toll-like receptor 4 (TLR4)-NF-κB signalling.	TLR4 ELANE	3.70e-05	2	212	2	34076894
Pubmed	VIP impairs acquisition of the macrophage proinflammatory polarization profile.	VIPR1 VIPR2	3.70e-05	2	212	2	27381006
Pubmed	The anti-aging protein Klotho affects early postnatal myogenesis by downregulating Jmjd3 and the canonical Wnt pathway.	KDM6B KL	3.70e-05	2	212	2	35174906
Pubmed	Broad activation of the ubiquitin-proteasome system by Parkin is critical for mitophagy.	PRKN NBR1	3.70e-05	2	212	2	21296869
Pubmed	Activation of dopamine neurons is critical for aversive conditioning and prevention of generalized anxiety.	GRIN1 SLC6A3	3.70e-05	2	212	2	21499253
Pubmed	Glucocorticoid signaling is perturbed by the atypical orphan receptor and corepressor SHP.	NR0B2 PCK1	3.70e-05	2	212	2	12324453
Pubmed	Targeted resequencing implicates the familial Mediterranean fever gene MEFV and the toll-like receptor 4 gene TLR4 in Behçet disease.	MEFV TLR4	3.70e-05	2	212	2	23633568
Pubmed	Palmitate-TLR4 signaling regulates the histone demethylase, JMJD3, in macrophages and impairs diabetic wound healing.	KDM6B TLR4	3.70e-05	2	212	2	32662520
Pubmed	Epigenetic Dysregulation of the Dynamin-Related Protein 1 Binding Partners MiD49 and MiD51 Increases Mitotic Mitochondrial Fission and Promotes Pulmonary Arterial Hypertension: Mechanistic and Therapeutic Implications.	MIEF1 MIEF2	3.70e-05	2	212	2	29431643
Pubmed	Prediction of the coding sequences of unidentified human genes. XXI. The complete sequences of 60 new cDNA clones from brain which code for large proteins.	PKD1L2 STK11IP ESCO1 LENG8 CSMD1	4.23e-05	63	212	5	11572484
Pubmed	A role for Nr-CAM in the patterning of binocular visual pathways.	CHL1 CNTN1 CNTN4	4.72e-05	12	212	3	16701205
Pubmed	Planar cell polarity genes control the connectivity of enteric neurons.	KIT RET CELSR3	4.72e-05	12	212	3	23478408
Pubmed	Pioneering axons regulate neuronal polarization in the developing cerebral cortex.	CHL1 CNTN1 CNTN4	6.11e-05	13	212	3	24559674
Pubmed	Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis.	SPART CHD3 TBC1D1 UCHL5 KIT GCN1 POLD1 RPAP1 PCNT	6.93e-05	285	212	9	32838362
Pubmed	Mutations in mice that influence natural killer (NK) cell activity.	KIT AP3B1 HR	7.74e-05	14	212	3	6971254
Pubmed	Overexpression of vasoactive intestinal peptide receptors and cyclooxygenase-2 in human prostate cancer. Analysis of potential prognostic relevance.	VIPR1 VIPR2	1.11e-04	3	212	2	22763881
Pubmed	PCSK9 Induces Tissue Factor Expression by Activation of TLR4/NFkB Signaling.	PCSK9 TLR4	1.11e-04	3	212	2	34884442
Pubmed	Postingestive Modulation of Food Seeking Depends on Vagus-Mediated Dopamine Neuron Activity.	GRIN1 SLC6A3	1.11e-04	3	212	2	32259476
Pubmed	Non-redundant roles in sister chromatid cohesion of the DNA helicase DDX11 and the SMC3 acetyl transferases ESCO1 and ESCO2.	ESCO1 ESCO2	1.11e-04	3	212	2	31935221
Pubmed	Clinical Relevance of VPAC1 Receptor Expression in Early Arthritis: Association with IL-6 and Disease Activity.	VIPR1 VIPR2	1.11e-04	3	212	2	26881970
Pubmed	Drp1-dependent mitochondrial fission via MiD49/51 is essential for apoptotic cristae remodeling.	MIEF1 MIEF2	1.11e-04	3	212	2	26903540
Pubmed	Three M Syndrome	CCDC8 OBSL1	1.11e-04	3	212	2	20301654
Pubmed	Pro-survival role for Parkinson's associated gene DJ-1 revealed in trophically impaired dopaminergic neurons.	RET SLC6A3	1.11e-04	3	212	2	20386724
Pubmed	Stress-responsive maturation of Clk1/4 pre-mRNAs promotes phosphorylation of SR splicing factor.	CLK4 CLK1	1.11e-04	3	212	2	21949414
Pubmed	Transposable elements controlling genetic instabilities in mammals.	KIT AP3B1	1.11e-04	3	212	2	6279728
Pubmed	Neutrophil elastase promotes Leishmania donovani infection via interferon-β.	TLR4 ELANE	1.11e-04	3	212	2	31284755
Pubmed	Parkin disrupts the alpha-synuclein/dopamine transporter interaction: consequences toward dopamine-induced toxicity.	SLC6A3 PRKN	1.11e-04	3	212	2	17873367
Pubmed	A secreted protein promotes cleavage furrow maturation during cytokinesis.	MYH10 HMCN2	1.11e-04	3	212	2	21215633
Pubmed	A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosis.	KIT IL9R	1.11e-04	3	212	2	28090087
Pubmed	A Multi-Trait Approach Identified Genetic Variants Including a Rare Mutation in RGS3 with Impact on Abnormalities of Cardiac Structure/Function.	CHD3 MRPL38	1.11e-04	3	212	2	30971721
Pubmed	MiD49 and MiD51, new components of the mitochondrial fission machinery.	MIEF1 MIEF2	1.11e-04	3	212	2	21508961
Pubmed	Releasing Syntaphilin Removes Stressed Mitochondria from Axons Independent of Mitophagy under Pathophysiological Conditions.	SNPH PRKN	1.11e-04	3	212	2	28472658
Pubmed	Regulation of amyloid precursor protein expression and secretion via activation of ERK1/2 by hepatocyte growth factor in HEK293 cells transfected with APP751.	HGF ANKS1B	1.11e-04	3	212	2	12837293
Pubmed	Vasoactive intestinal peptide/vasoactive intestinal peptide receptor relative expression in salivary glands as one endogenous modulator of acinar cell apoptosis in a murine model of Sjögren's syndrome.	VIPR1 VIPR2	1.11e-04	3	212	2	22059987
Pubmed	Nuclear localization of vasoactive intestinal peptide (VIP) receptors in human breast cancer.	VIPR1 VIPR2	1.11e-04	3	212	2	20691743
Pubmed	Regulation of allergic airway inflammation through Toll-like receptor 4-mediated modification of mast cell function.	KIT TLR4	1.11e-04	3	212	2	16461458
Pubmed	A mechanism for the initiation of allergen-induced T helper type 2 responses.	KIT TLR4	1.11e-04	3	212	2	18300366
Pubmed	Toll-like receptor stimulation differentially regulates vasoactive intestinal peptide type 2 receptor in macrophages.	VIPR2 TLR4	1.11e-04	3	212	2	20196778
Pubmed	Alternative catalytic residues in the active site of Esco acetyltransferases.	ESCO1 ESCO2	1.11e-04	3	212	2	32555289
Pubmed	Loss of Kitlow progenitors, reduced stem cell factor and high oxidative stress underlie gastric dysfunction in progeric mice.	KL KIT	1.11e-04	3	212	2	20581042
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	CHL1 IGFN1 LRIT3 PXDN HMCN2 CNTN1 CNTN4 OBSL1 LINGO2 WFIKKN2 MYBPC2	5.79e-08	161	142	11	593
GeneFamily	CDC like kinases	CLK4 CLK1 CLK3	1.89e-06	4	142	3	480
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	CFHR5 SVEP1 CR2 SEZ6L2 CSMD1	8.40e-05	57	142	5	1179
GeneFamily	Immunoglobulin like domain containing	CHL1 HMCN2 KIT CNTN1 CNTN4 LAG3 OBSL1 ICAM5	1.45e-04	193	142	8	594
GeneFamily	Vasoactive intestinal peptide receptor family	VIPR1 VIPR2	1.83e-04	3	142	2	264
GeneFamily	Cadherin related	CLSTN3 FAT4 RET	2.98e-04	17	142	3	24
GeneFamily	Immunoglobulin kappa locus at 2p11.2	IGKV1D-37 IGKV1D-13 IGKV1-37 IGKV1-13 IGKV1-9	4.95e-04	83	142	5	351
GeneFamily	Glutamate ionotropic receptor NMDA type subunits	GRIN3B GRIN1	1.25e-03	7	142	2	1201
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	CHL1 CLSTN3 MYH10 PTGIR SVEP1 MRC2 TAGLN PLEKHH2 CNTN4 POLD1 KIAA1755 PDZRN3 MYO16	1.25e-11	199	209	13	8b86c69aaf60feff53aa782559cfece7342a23de
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	CHL1 HGF MYH10 PTGIR SVEP1 MRC2 TAGLN PLEKHH2 CNTN4 POLD1 PDZRN3 MYO16	1.97e-10	199	209	12	06a7d874ff7c4616577f6e59d3118717a8c47c00
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	CHL1 HGF MYH10 PTGIR SVEP1 MRC2 TAGLN PLEKHH2 CNTN4 POLD1 PDZRN3 MYO16	1.97e-10	199	209	12	ba586690f88fd051f449753bfe7603a2cb431782
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	CHL1 CLSTN3 MYH10 PTGIR SVEP1 MRC2 TAGLN PLEKHH2 POLD1 PDZRN3 MYO16	2.86e-09	199	209	11	fde2b65afde69f402f1b7b056eaa266e9fd5b227
ToppCell	LPS_only-Mesenchymal_fibroblastic\|LPS_only / Treatment groups by lineage, cell group, cell type	CHL1 HGF MYH10 PTGIR SVEP1 MRC2 TAGLN PLEKHH2 POLD1 PDZRN3 MYO16	2.86e-09	199	209	11	211c3a08f2d484ab7a3368006767289088f0d957
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	CHL1 HGF MYH10 PTGIR SVEP1 MRC2 TAGLN PLEKHH2 POLD1 PDZRN3 MYO16	2.86e-09	199	209	11	e1849505b92820a219c5a2c35492bdd55579fb48
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts\|LPS_only / Treatment groups by lineage, cell group, cell type	CHL1 HGF MYH10 PTGIR SVEP1 MRC2 TAGLN PLEKHH2 POLD1 PDZRN3 MYO16	2.86e-09	199	209	11	1a0add79f4e34078b3475eb11c85a4234bda197c
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGFN1 SLC6A17 PKD1L2 COL24A1 CNTN1 ATP13A4 FAT4 SALL4 CSMD1 MYO16	1.79e-08	184	209	10	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGFN1 SLC6A17 PKD1L2 COL24A1 CNTN1 ATP13A4 FAT4 SALL4 CSMD1 MYO16	1.79e-08	184	209	10	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGFN1 SLC6A17 PKD1L2 COL24A1 CNTN1 ATP13A4 FAT4 SALL4 CSMD1 MYO16	1.79e-08	184	209	10	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 MYH10 PTGIR SVEP1 MRC2 TAGLN PLEKHH2 CNTN4 PDZRN3 MYO16	2.30e-08	189	209	10	a153b83314cf52808f685296cff8c95af3f4983d
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 MYH10 PTGIR SVEP1 MRC2 TAGLN PLEKHH2 CNTN4 PDZRN3 MYO16	2.30e-08	189	209	10	e9d5e858e320c6e9913c1ea6a54967d21eda605f
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 MYH10 PTGIR SVEP1 MRC2 PLEKHH2 CNTN4 KIAA1755 PDZRN3 MYO16	2.42e-08	190	209	10	45df8fee00f8949937863159d7aa042e72748d9b
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 HGF MYH10 PTGIR SVEP1 MRC2 PLEKHH2 CNTN4 PDZRN3 MYO16	2.55e-08	191	209	10	b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 HGF MYH10 SVEP1 MRC2 TAGLN PLEKHH2 CNTN4 PDZRN3 MYO16	2.67e-08	192	209	10	3d0cb19f037f604253d7d728689aeaa94251e92b
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 HGF MYH10 SVEP1 MRC2 TAGLN PLEKHH2 CNTN4 PDZRN3 MYO16	2.67e-08	192	209	10	6f4ef24dab544681304b7f8a9dc073e7edaa4cf5
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 MYH10 PTGIR SVEP1 MRC2 TAGLN PLEKHH2 CNTN4 PDZRN3 MYO16	2.67e-08	192	209	10	f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b
ToppCell	LPS-IL1RA-Stromal_mesenchymal\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 MYH10 PTGIR SVEP1 MRC2 TAGLN PLEKHH2 CNTN4 PDZRN3 MYO16	2.67e-08	192	209	10	4e47a02007f562f29ba5910df64d32a0167d0bd1
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	CHL1 MYH10 PTGIR SVEP1 MRC2 TAGLN CNTN4 POLD1 PDZRN3 MYO16	3.75e-08	199	209	10	38ed3bc7daa993d9edcf3e7834597ebb06dd24f8
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	CHL1 HGF MYH10 SVEP1 MRC2 PLEKHH2 CNTN4 CPXM1 PDZRN3 MYO16	3.93e-08	200	209	10	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	CHL1 HGF MYH10 PTGIR SVEP1 MRC2 TAGLN PLEKHH2 POLD1 MYO16	3.93e-08	200	209	10	ab4fda0cc95cb8f80ea9f28745013f3248def820
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	CHL1 HGF MYH10 PTGIR SVEP1 MRC2 TAGLN PLEKHH2 PDZRN3 MYO16	3.93e-08	200	209	10	b79628fd1386aa9a3b0e9fa81def0bc100c3c073
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	CHL1 HGF MYH10 PTGIR SVEP1 MRC2 TAGLN PLEKHH2 PDZRN3 MYO16	3.93e-08	200	209	10	50ca6550998e461ef26dd670351060bd940765a8
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	CHL1 HGF MYH10 PTGIR SVEP1 MRC2 TAGLN PLEKHH2 PDZRN3 MYO16	3.93e-08	200	209	10	3bdba9612cd7c612b76aa9abecc4a6529aabfc1c
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	CHL1 HGF MYH10 PTGIR SVEP1 MRC2 TAGLN PLEKHH2 PDZRN3 MYO16	3.93e-08	200	209	10	44a68bacdb3d5bf563bd35952176995850933a81
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	CHL1 HGF MYH10 PTGIR SVEP1 MRC2 TAGLN PLEKHH2 PDZRN3 MYO16	3.93e-08	200	209	10	dc61016c61729f69649cfb21f6264e685ce83dea
ToppCell	droplet-Kidney-nan-3m-Epithelial-Pecam____kidney_capillary_endothelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCDC8 SACS MRC2 ASIC4 PLEKHH2 TDRD5 LINGO2 PLA2R1 P2RX1	1.29e-07	172	209	9	073a503dc922e3e3ac3528e249b0f8b74402110b
ToppCell	facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_acinar_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GLS2 MYO9A EXTL1 PKD1L2 PHGDH NR0B2 VIPR2 P2RX1 MYO16	1.43e-07	174	209	9	4289dfc7613db4bb3d706b9b65d06e84c0c53558
ToppCell	facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_acinar_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GLS2 MYO9A EXTL1 PKD1L2 PHGDH NR0B2 VIPR2 P2RX1 MYO16	1.43e-07	174	209	9	165e14cad57e90aa247dcecfaa3c2e8ff2a470ad
ToppCell	facs-MAT-Fat-3m-Lymphocytic-T_cell\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTGIR FAAH LPCAT2 SACS KIT CNTN1 IVNS1ABP MYO16 IL9R	1.57e-07	176	209	9	71b3309ddadd035a1224fca4fc5946dc4c0283fe
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 HGF SVEP1 MRC2 TAGLN PLEKHH2 CNTN4 PDZRN3 MYO16	3.01e-07	190	209	9	841cd55861b43578d704418b9bc0af2e8b88323a
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 HGF PTGIR SVEP1 TAGLN PLEKHH2 CNTN4 PDZRN3 MYO16	3.01e-07	190	209	9	d60395739458d7f47a3350ade751fe3819500320
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 MYH10 PTGIR SVEP1 TAGLN PLEKHH2 CNTN4 PDZRN3 MYO16	3.29e-07	192	209	9	ee085e04d5dcfb657522484ed20b8c1ddeccfe0c
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 MYH10 PTGIR SVEP1 TAGLN CNTN4 KIAA1755 PDZRN3 MYO16	3.29e-07	192	209	9	df1545670370fb1010c567cd059c2783eab315f7
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 MYH10 SVEP1 MRC2 TAGLN PLEKHH2 CNTN4 PDZRN3 MYO16	3.29e-07	192	209	9	dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708
ToppCell	LPS_only-Stromal_mesenchymal\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 MYH10 PTGIR SVEP1 TAGLN PLEKHH2 CNTN4 PDZRN3 MYO16	3.29e-07	192	209	9	162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 HGF MYH10 SVEP1 MRC2 PLEKHH2 CNTN4 PDZRN3 MYO16	3.29e-07	192	209	9	deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 HGF MYH10 SVEP1 MRC2 PLEKHH2 CNTN4 PDZRN3 MYO16	3.44e-07	193	209	9	fb28717fadd06c3840636d25409ce80c9254bd34
ToppCell	LA\|World / Chamber and Cluster_Paper	ANKS1B SVEP1 PXDN HMCN2 MRC2 TAGLN PLEKHH2 CNTN4 PCK1	3.44e-07	193	209	9	d4bf89437216baf489ea0239136dcedf3b6714af
ToppCell	LPS-antiTNF-Stromal_mesenchymal\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 MYH10 SVEP1 MRC2 TAGLN PLEKHH2 CNTN4 PDZRN3 MYO16	3.59e-07	194	209	9	6e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 MYH10 SVEP1 MRC2 PLEKHH2 CNTN4 KIAA1755 PDZRN3 MYO16	3.59e-07	194	209	9	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 HGF MYH10 SVEP1 MRC2 PLEKHH2 CNTN4 PDZRN3 MYO16	3.59e-07	194	209	9	60622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	CHL1 HGF MYH10 SVEP1 MRC2 TAGLN PLEKHH2 PDZRN3 MYO16	4.08e-07	197	209	9	fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HGF MYH10 IGFN1 PTGIR SVEP1 MRC2 PLEKHH2 FAT4 PDZRN3	4.08e-07	197	209	9	94a9603cbd3516fbcce871909693b88f20d41713
ToppCell	background-Hepatic_Stellate_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	HGF PTGIR SVEP1 TAGLN PLEKHH2 CNTN4 VIPR1 ANGPTL6 PDZRN3	4.26e-07	198	209	9	bd11b0e9e80449aab979a02c1023e0638c431c7c
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	CHL1 HGF MYH10 SVEP1 MRC2 PLEKHH2 CNTN4 PDZRN3 MYO16	4.44e-07	199	209	9	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	FBXO17 SVEP1 TMEM200B PXDN MRC2 PLEKHH2 FAT4 CPXM1 PDZRN3	4.44e-07	199	209	9	21335475bbfbad8a6943b8076a6c1c67f3eec5d3
ToppCell	Control_saline-Mesenchymal_fibroblastic\|Control_saline / Treatment groups by lineage, cell group, cell type	CHL1 HGF MYH10 PTGIR SVEP1 MRC2 PLEKHH2 PDZRN3 MYO16	4.63e-07	200	209	9	64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	CHL1 HGF MYH10 PTGIR SVEP1 MRC2 PLEKHH2 PDZRN3 MYO16	4.63e-07	200	209	9	a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts\|Control_saline / Treatment groups by lineage, cell group, cell type	CHL1 HGF MYH10 PTGIR SVEP1 MRC2 PLEKHH2 PDZRN3 MYO16	4.63e-07	200	209	9	a1fc74c1b27e104895910bc7cdce7ba33d30df7e
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	CHL1 HGF MYH10 PTGIR SVEP1 MRC2 PLEKHH2 PDZRN3 MYO16	4.63e-07	200	209	9	bd8cf33502adea320e91ca2af14e1911d88ad374
ToppCell	Children_(3_yrs)-Mesenchymal-chondrocyte-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SNPH FBXO17 SVEP1 COL24A1 PLEKHH2 MROH2B KIAA1755 PDZRN3	8.40e-07	158	209	8	e5636c0b608d68bd426a2b446ac508e4512e86a4
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ANKS1B CNTN4 ABCC6 SLC28A1 KIAA1755 CSMD1 PCK1 L3MBTL4	1.97e-06	177	209	8	2f81b26be89cc2fd8eafadaf7eae3c6ad6521462
ToppCell	droplet-Marrow-nan-3m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HGF CCDC8 CHD3 FAAH NIBAN1 KLF6 LAG3 P2RX1	1.97e-06	177	209	8	c1f838e425ebb04482829b1957e3c1347127e6de
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ANKS1B CNTN4 ABCC6 SLC28A1 KIAA1755 CSMD1 PCK1 L3MBTL4	2.85e-06	186	209	8	a417e1e21313a7e05951038cdef5ac672a9f727c
ToppCell	COVID-19-Heart-Fib_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ANKS1B PTGIR GASK1B SVEP1 PXDN HMCN2 MRC2 KIAA1755	3.09e-06	188	209	8	fe361215f4ba841aa5e1e581fb56f2f4d3ccd201
ToppCell	droplet-Lung-30m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MYH10 SVEP1 MRC2 TAGLN CNTN1 VIPR2 PLA2R1 PDZRN3	3.61e-06	192	209	8	ff4b728a55c2550c806c47e9ae3d057c35df8464
ToppCell	droplet-Lung-30m-Mesenchymal-fibroblast-alveolar_fibroblast\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MYH10 SVEP1 MRC2 TAGLN CNTN1 VIPR2 PLA2R1 PDZRN3	3.61e-06	192	209	8	2d3790bd80a7f214b37094121a2a86ff16362569
ToppCell	3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HGF CCDC8 SPART PTGIR SVEP1 MRC2 VIPR2 MROH2B	3.89e-06	194	209	8	e2db75f4de114631b8bda4e188f84446545538b7
ToppCell	LAM-LAM-LAM+\|LAM / Condition, Lineage and Cell class	IGFN1 FBXO17 TMEM200B NR0B1 TAGLN KIAA1755 CPXM1 PDZRN3	3.89e-06	194	209	8	4ba73a9145ed44896e359f6df9c1f32bbe24a189
ToppCell	LAM-LAM\|LAM / Condition, Lineage and Cell class	IGFN1 FBXO17 TMEM200B NR0B1 TAGLN KIAA1755 CPXM1 PDZRN3	3.89e-06	194	209	8	4c6561a64711c72c4ef4a3e67c41d2e8d31fba57
ToppCell	COVID-19-Heart-Fib_1\|Heart / Disease (COVID-19 only), tissue and cell type	ANKS1B PTGIR GASK1B SVEP1 PXDN MRC2 PLEKHH2 KIAA1755	4.04e-06	195	209	8	f423baa36ac7cdc383c033e35a7d17e6bf913323
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	CHL1 HGF MYH10 SVEP1 MRC2 TAGLN PLEKHH2 MYO16	4.53e-06	198	209	8	0a4b19c3d5e65ecd24fc2ce80ac5276c813282c7
ToppCell	tumor_Lung-Fibroblasts-COL13A1+_matrix_FBs\|tumor_Lung / Location, Cell class and cell subclass	HGF CCDC8 MYH10 FBXO17 PTGIR SVEP1 PLEKHH2 PDZRN3	4.53e-06	198	209	8	2d7842f352273b6b823c86eb548b9f4a4cddf0ae
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHL1 MYH10 GASK1B COL24A1 PXDN PLEKHH2 CNTN1 FAT4	4.53e-06	198	209	8	7582ee9ec8a87ecb094201f1f9191b412f9d2875
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	CHL1 HGF MYH10 SVEP1 MRC2 PLEKHH2 PDZRN3 MYO16	4.70e-06	199	209	8	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	Biopsy_IPF-Mesenchymal-Myofibroblasts\|Biopsy_IPF / Sample group, Lineage and Cell type	HGF MYH10 PTGIR MRC2 TAGLN PLEKHH2 FAT4 PDZRN3	4.87e-06	200	209	8	c2c6f687c49ba790174b27c7b8b084af30b34c86
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	HGF MRC2 TAGLN PLEKHH2 CNTN1 PCED1A CNTN4 VIPR2	4.87e-06	200	209	8	cf883ba5dbe6350b93142d625a52b25ff2a8bb63
ToppCell	Parenchymal-10x5prime-Stromal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MYH10 PTGIR SVEP1 MRC2 TAGLN PLEKHH2 CPXM1 PDZRN3	4.87e-06	200	209	8	2e525c0d9684e7a2275edb04e1addb6fc6a872e5
ToppCell	wk_15-18-Mesenchymal-Fibroblast\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	MYH10 FBXO17 SVEP1 PXDN MRC2 PLEKHH2 CNTN1 CPXM1	4.87e-06	200	209	8	4f624c3c57d1a84baa86d0830cb1b83ae110bf67
ToppCell	Children_(3_yrs)-Mesenchymal-chondrocyte\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SNPH FBXO17 SVEP1 COL24A1 PLEKHH2 KIAA1755 PDZRN3	9.54e-06	157	209	7	f147e24f2ece82e1c54750868954d09b3c461804
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-Pericyte_2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CLSTN3 SVEP1 STRC PLEKHH2 PCSK9 PCED1A DNHD1	9.94e-06	158	209	7	7f5426585d0d299d2b48e5fcb349950feffdef33
ToppCell	343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	VIPR1 NIBAN1 THEMIS KLF6 FRMPD1 LAG3 ULBP1	1.08e-05	160	209	7	21f7c0337fbd99e4a20650920d8302d7318bd25e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SPART PTGIR SVEP1 MRC2 CNTN1 RET KIAA1755	1.17e-05	162	209	7	bfaeff19bb56598fdc8c82be71d51787cf13928f
ToppCell	Bronchial_Biopsy-Immune-Neutrophils\|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X	CLSTN3 SGSM1 WDR93 TSEN34 VIPR1 THEMIS ABCC6	1.17e-05	162	209	7	985adca17b0c99563feef7910f3da5df31e636b6
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-Like\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	AADACL4 ASIC4 ASTE1 SALL4 LINGO2 SLC6A3	1.34e-05	110	209	6	c80d1c3df75648e2c8f6832279c2acca63d76681
ToppCell	facs-Lung-nan-3m-Epithelial-type_I_pneumocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPPK1 ATP13A4 FRMPD1 WDR27 PRKN PDZRN3 MYO16	1.37e-05	166	209	7	11b0ae82b3068ef91715dbdd49fe8e9791b4a480
ToppCell	facs-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_1\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPPK1 ATP13A4 FRMPD1 WDR27 PRKN PDZRN3 MYO16	1.37e-05	166	209	7	fcc1aec31ebd39432d4cb284dc8fadf34e3c566a
ToppCell	10x5'-bone_marrow-Hematopoietic_progenitors-Progenitor_pre-Lymphocytic-T\|bone_marrow / Manually curated celltypes from each tissue	HGF SPART PHGDH PLA2R1 ELANE CPXM1 CSMD1	1.37e-05	166	209	7	20f248d95c86eb52a1efe9abe73123fbe4206caf
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGFN1 SLC6A17 LENG8 MIEF2 PCED1A SEZ6L2 PRKN	1.43e-05	167	209	7	b94e8ee8c3fcebedd8fcd719eadddc04c7513c50
ToppCell	5'-Adult-Appendix-Hematopoietic-Myeloid-Lymphoid_DC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ADGRB1 PTGIR STRC GRIN3B GRIN1 CR2 ANGPTL6	1.43e-05	167	209	7	8b223333c0c7a85b5a1af6f2f5b12ee0d94357f6
ToppCell	Thalamus-Macroglia-OLIGODENDROCYTE-O1-Trf\|Thalamus / BrainAtlas - Mouse McCarroll V32	SPART ITGAD PHGDH CCDC187 SALL4 LCTL	1.49e-05	112	209	6	cb351e57c99aaaf9ae6c7ff7e8ce5375552b1639
ToppCell	Thalamus-Macroglia-OLIGODENDROCYTE-O1-Trf-Oligodendrocyte.Trf.Il33_(Il33)\|Thalamus / BrainAtlas - Mouse McCarroll V32	SPART ITGAD PHGDH CCDC187 SALL4 LCTL	1.49e-05	112	209	6	999b5eeed4305e1a1385aadbaf017b64f21c1ee0
ToppCell	Thalamus-Macroglia-OLIGODENDROCYTE-O1-Trf-Oligodendrocyte.Trf.Il33_(Il33)-\|Thalamus / BrainAtlas - Mouse McCarroll V32	SPART ITGAD PHGDH CCDC187 SALL4 LCTL	1.49e-05	112	209	6	004cd69b66c3b26b9a61f03279b48230da351574
ToppCell	Thalamus-Macroglia-OLIGODENDROCYTE-O1\|Thalamus / BrainAtlas - Mouse McCarroll V32	SPART ITGAD PHGDH CCDC187 SALL4 LCTL	1.49e-05	112	209	6	502e3f356f6e1c959bff0a39c98f33f863ce8265
ToppCell	TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-6\|TCGA-Liver / Sample_Type by Project: Shred V9	IGFN1 KIF26A PTGIR SVEP1 CNTN4 NIBAN1 PDZRN3	1.54e-05	169	209	7	e992530776cab922d0360b275fb9cb8bd0017b06
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHL1 HGF SVEP1 PXDN PLEKHH2 FAT4 PDZRN3	1.54e-05	169	209	7	c0824a93674e2bff0f09b2d2fab5bab016a2e379
ToppCell	390C-Myeloid-Dendritic-cDC_proliferating_1\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	IMPA2 PHGDH FAAH DNA2 NR0B2 TROAP ESCO2	1.72e-05	172	209	7	6fcc16f1067672967ecbcdfdc727649ae9891dd9
ToppCell	facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l15\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PHLDA3 PTGIR ZNF688 TAGLN XKR8 SNUPN KIAA1755	1.72e-05	172	209	7	de4961f4037c439d3e0ec706a257b0ec17f4d5be
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SLC6A17 SPART GASK1B TAGLN UBR4 LAS1L HYAL2	1.86e-05	174	209	7	d77fa525d5c87c190b4a10787b270eabd16c610f
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Sema3e_Kank4\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	IMPA2 TSPAN9 BTN2A2 NIBAN1 FRMPD1 CR2	2.00e-05	118	209	6	d7dcffc0476a6e471debd83904a6569c6f27a594
ToppCell	5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_A\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KIF26A ANKS1B GPR179 GRIN1 RET CELSR3 TMEM179	2.00e-05	176	209	7	116741fef5895ca85057d2d31eca9eba5764ab44
ToppCell	5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_A-Branch_A1_(iMN)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KIF26A ANKS1B GPR179 GRIN1 RET CELSR3 TMEM179	2.00e-05	176	209	7	5b707f58d164ee7a6a527dd5d053472ce9a631c1
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage_3\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	CHL1 FBXO17 SVEP1 PXDN FAT4 KIAA1755 PDZRN3	2.07e-05	177	209	7	3d955ea938a1d2fb1b6d68d4997fd454bd632dfc
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10\|TCGA-Colorectal / Sample_Type by Project: Shred V9	CCDC8 MYH10 SLC6A17 MEFV SVEP1 COL24A1 PXDN	2.23e-05	179	209	7	cc079ba015326dccde955c5eafa3e4a2e40de192
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ANKS1B CNTN4 ABCC6 ICAM5 SLC28A1 KIAA1755 PCK1	2.23e-05	179	209	7	d1ef7e1cb00336118e387b47f4f8120f53584391
ToppCell	facs-Large_Intestine-Proximal-18m-Epithelial-enteroendocrine_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABHD15 CNTN4 FFAR1 FAM131A SEZ6L2 CELSR3 MAPK8IP2	2.31e-05	180	209	7	9db9899ca42455310e9b63df523fe6c4780abfb7
ToppCell	moderate-Myeloid-pDC\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	ABHD15 COL24A1 VIPR2 TTC24 RET P2RX1 PDZRN3	2.31e-05	180	209	7	a0751ad5e42a21cb107d900abfa9ee967a0069fc
ToppCell	facs-Marrow-Granulocytes-3m-Lymphocytic-mature_alpha-beta_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACSS1 SACS CLK3 SHCBP1L TDRD5 TMEM79 P2RX1	2.39e-05	181	209	7	41969fe4d94ee77b12ecde32170aaf0b13e49644
ToppCell	3'_v3-bone_marrow-Mast-Mast_cells\|bone_marrow / Manually curated celltypes from each tissue	HGF LPCAT2 KLHDC7A KIT OBSL1 CACNG6 P2RX1	2.39e-05	181	209	7	30ec4635474ee0f0ea1415ec0ba7f008d97e8c1a
Disease	Colorectal Carcinoma	CHL1 CLSTN3 KMT2C KL SACS CNTN1 CNTN4 POLD1 TSPEAR APC ZDHHC7 RET ABCC6 RPAP1 ICAM5 TLR4 LAS1L HR	1.48e-06	702	199	18	C0009402
Disease	pulmonary emphysema (implicated_via_orthology)	KL TLR4 ELANE	8.22e-05	13	199	3	DOID:9675 (implicated_via_orthology)
Disease	3-M syndrome	CCDC8 OBSL1	1.35e-04	3	199	2	cv:C1848862
Disease	3-M syndrome (is_implicated_in)	CCDC8 OBSL1	1.35e-04	3	199	2	DOID:0060241 (is_implicated_in)
Disease	vision disorder	MYH10 PXDN CNTN1	1.59e-04	16	199	3	MONDO_0021084
Disease	Liver carcinoma	HGF KMT2C NR0B2 VIPR1 TROAP APC ANGPTL6 SCAP CELSR3 TLR4 CSMD1 PCK1	1.84e-04	507	199	12	C2239176
Disease	Intellectual Disability	CHL1 CHD3 KDM6B KMT2C SACS TSEN34 APC GRIN1 CERT1 SLC6A3 LAS1L	2.45e-04	447	199	11	C3714756
Disease	Roberts syndrome (implicated_via_orthology)	ESCO1 ESCO2	2.69e-04	4	199	2	DOID:5325 (implicated_via_orthology)
Disease	Chronic myeloproliferative disorder	JAK3 KIT PCNT	2.70e-04	19	199	3	C1292778
Disease	Squamous cell carcinoma of esophagus	KMT2C TAGLN FAT4 SALL4 TXNDC17	4.70e-04	95	199	5	C0279626
Disease	Neoplasm of the genitourinary tract	KIT KLF6 PRKN	5.51e-04	24	199	3	cv:C0042065
Disease	butyrylcholinesterase measurement	TRIM58 RNPEP	6.67e-04	6	199	2	EFO_0004571
Disease	Glycosuria	ITGAD N4BP1	9.29e-04	7	199	2	HP_0003076
Disease	level of oxylipin in blood plasma	LPCAT2 KIAA1755	9.29e-04	7	199	2	OBA_2050338
Disease	contactin-4 measurement	CHL1 CNTN4	9.29e-04	7	199	2	EFO_0020287
Disease	Polyomavirus Infections	HGF GPR179	9.29e-04	7	199	2	C0949804
Disease	pheochromocytoma (is_implicated_in)	SDHD RET	9.29e-04	7	199	2	DOID:0050771 (is_implicated_in)
Disease	focal segmental glomerulosclerosis (implicated_via_orthology)	MYO9A HR	9.29e-04	7	199	2	DOID:1312 (implicated_via_orthology)
Disease	Developmental Academic Disorder	KL TLR4 PRKN	9.70e-04	29	199	3	C1330966
Disease	Learning Disorders	KL TLR4 PRKN	9.70e-04	29	199	3	C0023186
Disease	Learning Disturbance	KL TLR4 PRKN	9.70e-04	29	199	3	C0751263
Disease	Adult Learning Disorders	KL TLR4 PRKN	9.70e-04	29	199	3	C0751262
Disease	Learning Disabilities	KL TLR4 PRKN	9.70e-04	29	199	3	C0751265
Disease	fear of minor pain measurement	TRMT12 MAB21L3 PRKN	1.18e-03	31	199	3	EFO_0008340
Disease	response to antidepressant	ADGRB1 TBC1D1 CNTN1 LINGO2 WFIKKN2 PDZRN3	1.28e-03	176	199	6	GO_0036276
Disease	melanoma	PHGDH KIT SDHD FAT4 UBR4 RET TLR4	1.53e-03	248	199	7	C0025202
Disease	familial Mediterranean fever (is_implicated_in)	MEFV TLR4	1.58e-03	9	199	2	DOID:2987 (is_implicated_in)
Disease	Acute Myeloid Leukemia, M1	HGF KMT2C PXDN KIT CAPN2	1.62e-03	125	199	5	C0026998
Disease	Acute Myeloid Leukemia (AML-M2)	HGF KMT2C PXDN KIT CAPN2	1.62e-03	125	199	5	C1879321
Disease	cholesteatoma (is_marker_for)	HGF TLR4	1.97e-03	10	199	2	DOID:869 (is_marker_for)
Disease	interstitial lung disease (is_implicated_in)	HGF AP3B1	1.97e-03	10	199	2	DOID:3082 (is_implicated_in)
Disease	thioredoxin domain-containing protein 12 measurement	SHISA5 SCAP CELSR3	2.31e-03	39	199	3	EFO_0008298
Disease	Gastric cancer	KLF6 APC	2.39e-03	11	199	2	cv:C0024623
Disease	Neoplasm of stomach	KLF6 APC	2.39e-03	11	199	2	cv:C0038356
Disease	NG-monomethyl-arginine measurement	CSMD1 TDRD12	2.39e-03	11	199	2	EFO_0010510
Disease	GASTRIC CANCER	KLF6 APC	2.39e-03	11	199	2	613659
Disease	Night blindness, congenital stationary, type 1	LRIT3 GPR179	2.86e-03	12	199	2	C3501847
Disease	Night Blindness, Congenital Stationary, Type 1A	LRIT3 GPR179	2.86e-03	12	199	2	C3495587
Disease	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B (disorder)	LRIT3 GPR179	2.86e-03	12	199	2	C1864877
Disease	Carcinoma, Neuroendocrine	SDHD RET	2.86e-03	12	199	2	C0206695
Disease	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B	LRIT3 GPR179	2.86e-03	12	199	2	C1850362
Disease	X-Linked Csnb	LRIT3 GPR179	2.86e-03	12	199	2	C3711543
Disease	triacylglycerol 44:1 measurement	PRKN CSMD1	2.86e-03	12	199	2	EFO_0010399
Disease	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A	LRIT3 GPR179	2.86e-03	12	199	2	C1848172
Disease	Memory Loss	KL SLC6A3 PRKN	3.06e-03	43	199	3	C0751295
Disease	Age-Related Memory Disorders	KL SLC6A3 PRKN	3.06e-03	43	199	3	C0751292
Disease	Memory Disorder, Spatial	KL SLC6A3 PRKN	3.06e-03	43	199	3	C0751294
Disease	Memory Disorder, Semantic	KL SLC6A3 PRKN	3.06e-03	43	199	3	C0751293
Disease	Memory Disorders	KL SLC6A3 PRKN	3.06e-03	43	199	3	C0025261
Disease	Memory impairment	KL SLC6A3 PRKN	3.27e-03	44	199	3	C0233794
Disease	Cone-rod synaptic disorder, congenital nonprogressive	LRIT3 GPR179	3.36e-03	13	199	2	C4041558
Disease	putamen volume change measurement	SH2D3C MYO16	3.36e-03	13	199	2	EFO_0021495
Disease	response to angiotensin-converting enzyme inhibitor, Cough	PKD1L2 NIBAN1 CSMD1	3.71e-03	46	199	3	EFO_0005325, HP_0012735
Disease	Diabetic Neuralgia	HGF TLR4	3.90e-03	14	199	2	C0751074
Disease	Diabetic Neuropathies	HGF TLR4	3.90e-03	14	199	2	C0011882
Disease	Asymmetric Diabetic Proximal Motor Neuropathy	HGF TLR4	3.90e-03	14	199	2	C0271674
Disease	Symmetric Diabetic Proximal Motor Neuropathy	HGF TLR4	3.90e-03	14	199	2	C0271673
Disease	Diabetic Mononeuropathy	HGF TLR4	3.90e-03	14	199	2	C0271678
Disease	Diabetic Autonomic Neuropathy	HGF TLR4	3.90e-03	14	199	2	C0271686
Disease	Diabetic Amyotrophy	HGF TLR4	3.90e-03	14	199	2	C0271685
Disease	Diabetic Polyneuropathies	HGF TLR4	3.90e-03	14	199	2	C0271680
Disease	Adenocarcinoma Of Esophagus	SPART TLR4	3.90e-03	14	199	2	C0279628
Disease	Diabetic Asymmetric Polyneuropathy	HGF TLR4	3.90e-03	14	199	2	C0393835
Disease	diabetic neuropathy (is_implicated_in)	HGF TLR4	3.90e-03	14	199	2	DOID:9743 (is_implicated_in)
Disease	RS-6-hydroxywarfarin measurement	SGSM1 ANKS1B CNTN4 ATP13A4 N4BP1	4.10e-03	155	199	5	EFO_0803328
Disease	cannabis dependence measurement	LINGO2 RET CSMD1	4.18e-03	48	199	3	EFO_0008457
Disease	Non-Small Cell Lung Carcinoma	PHGDH KIT APC RET CERT1	4.21e-03	156	199	5	C0007131
Disease	QRS duration	CNTN1 FAT4 THEMIS UBR4 OBSL1 PDZRN3 MYBPC2	4.25e-03	298	199	7	EFO_0005055
Disease	osteoarthritis, knee	EPPK1 PCSK9 SNUPN AP3B1 BTNL2	4.45e-03	158	199	5	EFO_0004616
Disease	Hypogonadotropic hypogonadism	NR0B1 POLD1	4.49e-03	15	199	2	C0271623
Disease	Carcinoma of Endocrine Gland	SDHD RET	4.49e-03	15	199	2	C1704374
Disease	unipolar depression, cognitive function measurement	MYH10 CPXM1	4.49e-03	15	199	2	EFO_0003761, EFO_0008354
Disease	Primary hypogonadism	NR0B1 POLD1	4.49e-03	15	199	2	C0948896
Disease	Hypogonadism, Isolated Hypogonadotropic	NR0B1 POLD1	4.49e-03	15	199	2	C3489396
Disease	coronary artery disease (is_implicated_in)	KL ABCC6 BTNL2 TLR4	4.75e-03	100	199	4	DOID:3393 (is_implicated_in)
Disease	metabolite measurement	GLS2 PKD1L2 PHGDH FAAH ACOT2 PLEKHH2 PCSK9 RNPEP SLC28A1 CSMD1	4.92e-03	560	199	10	EFO_0004725
Disease	Hypogonadism	NR0B1 POLD1	5.10e-03	16	199	2	C0020619
Disease	Pheochromocytoma, Extra-Adrenal	SDHD RET	5.10e-03	16	199	2	C1257877
Disease	monoclonal gammopathy	CNTN4 PRKN CSMD1	5.52e-03	53	199	3	EFO_0000203
Disease	Benign neoplasm of stomach	KLF6 APC	5.76e-03	17	199	2	C0153943
Disease	Neoplasm of uncertain or unknown behavior of stomach	KLF6 APC	5.76e-03	17	199	2	C0496905
Disease	Keloid	PHLDA3 HYAL2	5.76e-03	17	199	2	EFO_0004212
Disease	Carcinoma in situ of stomach	KLF6 APC	5.76e-03	17	199	2	C0154060
Disease	Moyamoya Disease	ABCC6 PCNT	5.76e-03	17	199	2	C0026654
Disease	Night blindness, congenital stationary	LRIT3 GPR179	5.76e-03	17	199	2	C0339535
Disease	dermatomyositis (is_marker_for)	HGF TLR4	5.76e-03	17	199	2	DOID:10223 (is_marker_for)
Disease	Leukemia, Myelocytic, Acute	HGF KMT2C PXDN KIT CAPN2	6.49e-03	173	199	5	C0023467
Disease	amino acid measurement	MYH10 GLS2 TSPAN9 COL24A1 PXDN FAT4 LINGO2 PLA2R1 ELANE CSMD1 MYO16	6.57e-03	678	199	11	EFO_0005134

Protein segments in the cluster

Peptide	Gene	Start	Entry
AQAIPCSLAWVRPVE	TDRD5	586	Q8NAT2
PSEESWGCRQRASPL	nan	91	Q8NBF4
GSVICWCDQSVAPPR	nan	91	Q8N814
IRNCVNQEWPEGSSP	LINC01547	16	P58512
RTLGSVGEPINCEAW	ACSS1	411	Q9NUB1
VAAPLCISWQRPTGI	nan	161	Q9N2K0
VNDSVWVPGPTDDRC	ERVK-18	16	O42043
DVCVSWKERPPQVLG	CCDC187	126	A0A096LP49
TACETWEDPGPRLRN	CCDC187	546	A0A096LP49
AEVGPRSRVWAEPCL	RNPEP	241	Q9H4A4
PGIRLETCDEPLWNI	CLSTN3	266	Q9BQT9
GDRRVWDKPLPSCIA	CSMD1	1261	Q96PZ7
QLVCTARGWFPEPQV	BTNL2	161	Q9UIR0
WKETPAGEVAAVRCP	ADGRB1	591	O14514
ICGPNTIDVEVTPIW	ATP13A4	181	Q4VNC1
ACQDWTVPLPASAGR	ARHGEF5	881	Q12774
PLWAVPAIVGSCATV	FAT4	4501	Q6V0I7
TGVRSLQEIWPGCEI	ABHD18	381	Q0P651
PEVILELGWAQPCDV	CLK3	491	P49761
ECFALGNPVPTIIWR	CNTN4	246	Q8IWV2
PQTWLQGGAPCLRAE	CPXM1	256	Q96SM3
CGQPDPRWASINLGV	ACAP3	421	Q96P50
EGIDNIPPARWKLTC	BRPF3	311	Q9ULD4
CWDEPVRIAVRGLAP	ACOT2	76	P49753
LSWRDAILNGTCVPP	AADACL4	261	Q5VUY2
AILNGTCVPPDVWRK	AADACL4	266	Q5VUY2
LPNCEVVGVDWAEGL	DMAC2	226	Q9NW81
EPRLCGLSEGPQAWL	DNHD1	4391	Q96M86
ISAFLQDRPIPEWCG	SDHD	31	O14521
LWQADVPVDRDTCGP	CACNG6	91	Q9BXT2
VCPDALNLGLPEWVL	ASTE1	316	Q2TB18
DDGLVALDWVVGPCV	ABHD15	131	Q6UXT9
WLIGENCERVPKIAP	AP3B1	501	O00203
RAPEVILALGWSQPC	CLK1	346	P49759
PLNAEACWPKDVGIV	HMGCS1	6	Q01581
CVLPWVVQEGSCPAR	PDZRN3	41	Q9UPQ7
SQCPIIDAAWESPEG	PCK1	411	P35558
DRIPWVAPECLREAQ	JAK3	686	P52333
PASDWPEAVCLLIGR	ANAPC1	966	Q9H1A4
GPPVERCGVLSKWTN	CERT1	21	Q9Y5P4
TRPRCPVQTVGQWLE	ANKS1B	806	Q7Z6G8
CEVSPPDADVTWLRN	OBSL1	1381	O75147
DITEWAGCQRVGISP	DNAJC14	596	Q6Y2X3
FVVAWDVPTQDCGPR	HYAL2	36	Q12891
PCRDDGWSEQLPDTL	KMT2C	1316	Q8NEZ4
LCEAEGEPQPTIKWR	CHL1	351	O00533
LQCVAAGFPEPTIDW	KIT	426	P10721
DDWIPVPELRTNRCN	IVNS1ABP	441	Q9Y6Y0
EELPPLDQLFWGLRC	NUDT15	126	Q9NV35
CRPGEVCPWEAQEAA	GPR179	1796	Q6PRD1
EPPKEVCAEGNEAIW	LRRIQ4	481	A6NIV6
PEGASCNRLPSELWD	MYO16	1841	Q9Y6X6
ALCQAWGPLPLEALD	KIAA1755	196	Q5JYT7
LLCEARGVPTPNITW	HMCN2	1551	Q8NDA2
WVPGARCDIQLTQSP	IGKV1D-37	16	P0DSN7
ADPDWQELQIVGTCP	LENG8	541	Q96PV6
CVQALLREPAQPGLW	KDM6B	96	O15054
WQETALCSPAPEALR	MAPK8IP2	166	Q13387
WLPGARCAIQLTQSP	IGKV1D-13	16	A0A0B4J2D9
KTQRWAEPGEPICVV	DDX59	96	Q5T1V6
CWTLLQAPGEAVLVP	HR	1106	O43593
PAPQEQVTVACEEGW	PCSK9	616	Q8NBP7
WQPVGENFTLSCRVP	ICAM5	131	Q9UMF0
VGISLNCDWGEPVDI	LCTL	256	Q6UWM7
GPAPDLVIINSCLWD	PCED1A	131	Q9H1Q7
PAEEQLRGPCWDQSS	PINX1	256	Q96BK5
VICNWPPALESALQR	DIP2B	331	Q9P265
WICKIPRGTDVREPD	MRC2	806	Q9UBG0
CPQGLADSAWIPFRE	MRC2	1261	Q9UBG0
AWNNPSPRVECVLAE	LAS1L	296	Q9Y4W2
TPEPCKAIVWGDQRE	KIF26A	911	Q9ULI4
PVGWCQENGRTLIAP	L3MBTL4	246	Q8NA19
ECSADGDPQPVISWV	LINGO2	431	Q7L985
PDLWGVSLCTVDGQR	GLS2	191	Q9UI32
WAVRPQDLDTCDPRQ	MSLN	466	Q13421
RVISESPPDQWEARC	GCN1	1221	Q92616
SPPDQWEARCGLALA	GCN1	1226	Q92616
VVWAQEGAPAQLPCS	LAG3	31	P18627
PSRIILGLQDNPWFC	LRIT3	191	Q3SXY7
WERLPDGPQRFDSCI	MEFV	626	O15553
QPWGNCRAESELREP	ASIC4	291	Q96FT7
ESPWCFTTDPNIRVG	HGF	361	P14210
VPLVLEQNLWSCIPG	MIEF1	206	Q9NQG6
GWAVPRGCDPQTFLQ	PSMB11	26	A5LHX3
EVLEPWCPAAQGRLT	NR0B2	201	Q15466
PTWIIDPIDGTCNFV	IMPA2	96	O14732
EVPTACPDWRGDLLQ	PCNT	2441	O95613
NLPRLSAWVREQCPG	PLCXD1	276	Q9NUJ7
EPEGPVDWKERCVAL	PLEKHH2	6	Q8IVE3
LKEDIWCPGNRPVIT	MAB21L3	266	Q8N8X9
PLCQAVFGDPLWIQV	PKD1L2	361	Q7Z442
LQAVSWASGARPCIP	GBA	31	P04062
VSVCPLPRGRVQWQC	ITGAD	491	Q13349
APEAPETRLVDQCWG	NR0B1	26	P51843
EWPQILVFPEGTCTN	LPCAT2	211	Q7L5N7
ASPDPVLQWTERGCR	FBXO17	216	Q96EF6
FIQDGRPCPIILWDA	GASK1B	301	Q6UWH4
VPRQAPCEWAIRNIG	GIG44	16	P09565
IRCNAQGTWEPSAPV	CR2	391	P20023
NTPVNGSPVCLEAWD	FFAR1	161	O14842
CREAAMPAWGLEQRP	CUSTOS	26	Q96C57
AQAVVSTEAPWERPC	LINC01555	61	Q8NAE3
VNDSVWVPGPIDDRC	ERVK-7	16	P61567
DQLRISFPPGLCWGD	CHD3	16	Q12873
GQDIAPRDSPEWVCF	FRMPD1	1236	Q5SYB0
LECFALGNPVPDIRW	CNTN1	261	Q12860
PDARACELWQVLGAP	CRYBG2	321	Q8N1P7
REVIAPAGSEPWLCQ	IGFL2	21	Q6UWQ7
PRAWLAPTLQGICTA	ATOH1	61	Q92858
LCPPLTGSWERQRQA	FAM131A	331	Q6UXB0
TKPVGPWQDCAEARQ	ANGPTL6	251	Q8NI99
NISCVERGWSTPPIC	CFHR5	126	Q9BXR6
VNDSVWVPGPTDDRC	ERVK-5	16	Q9HDB8
DVPEPAVCGISRIWV	ESCO2	526	Q56NI9
WVDPNILCPLGSQEA	FOXR2	81	Q6PJQ5
TGIWSEVCPLNQARP	KLHDC7A	566	Q5VTJ3
NELIPQGICPVGRSW	KLHDC2	256	Q9Y2U9
ISIALQADWIEPACP	KL	726	Q9UEF7
WLPGARCDIQLTQSP	IGKV1-9	16	A0A0C4DH69
WLPGARCAIQLTQSP	IGKV1-13	16	P0DP09
WVPGARCDIQLTQSP	IGKV1-37	16	A0A075B6S9
WIDSIIQRSEDNPCP	ELANE	241	P08246
LPEPAICGISRIWVF	ESCO1	761	Q5FWF5
VVCGEPRPEVRWQNS	IGFN1	51	Q86VF2
PVAVQCVALPWQEEL	FAAH	546	O00519
PEVILALGWSQPCDV	CLK4	346	Q9HAZ1
PQTRGAPELSWCRAA	CELSR3	3021	Q9NYQ7
NPERFDSQPCVLGWE	BTN2A2	361	Q8WVV5
RGIEWKRPTEICADP	CAPN2	71	P17655
NAGDVCVPQASPRRW	CCDC8	251	Q9H0W5
ILRNDWCSVPVEPGD	DNA2	81	P51530
WDAQTGDCLTRIPRP	SCAP	801	Q12770
PGANSIPWVLEQILC	SALL4	206	Q9UJQ4
NRWVPVTVLPGCVGC	SACS	6	Q9NZJ4
QICSLGLRWGEPEPF	POLD1	336	P28340
CLGAQPVTDLALWPV	C3orf56	46	Q8N813
ANPPGVLALLDEECW	MYH10	526	P35580
QLPDCRGLEVWNSIP	IL17RC	261	Q8NAC3
ILQPRAAAVWPNGTC	PCARE	641	A6NGG8
PGVDTVARDPRCWAV	MIEF2	211	Q96C03
WEDVGLALCRTQDPG	GRIN3B	171	O60391
EAEAAPREGPVWLCS	GRIN3B	951	O60391
IFGWCPVEVDDDIPR	P2RX1	161	P51575
GEWPDQPRITKDVIC	RSBN1L	596	Q6PCB5
LPPAWRNCVSATEEE	STK11IP	911	Q8N1F8
AFWPNGILAEAVPCR	SNX13	851	Q9Y5W8
PVRVPSWGLEDNVVC	TAX1BP1	661	Q86VP1
DELRKCSWPGVPREV	TBC1D22B	201	Q9NU19
LTQGPSCWDDVLIPN	PRKN	176	O60260
RSPRAVGCAEPEIWD	TMEM200B	176	Q69YZ2
QQFGPRVWCSIIVDP	NBR1	466	Q14596
VCFGQELDPPWLERV	ABCC6	711	O95255
SWPPIARGCDVVVIS	TDRD12	446	Q587J7
RCRPQEDTGWLLFPV	EPPK1	2071	P58107
LWCDIQDGTIPGPIA	SHCBP1L	286	Q9BZQ2
VWSEERCAVPEASVP	SHISA5	66	Q8N114
VEWIIVQCGPDVGRP	TAGLN	31	Q01995
GPNLTCRWVIEAAEG	SEZ6L2	371	Q6UXD5
VPSDLGQEWIVVVCP	SNUPN	111	O95149
CGPARPWKSVALEEE	IL9R	361	Q01113
AVVVPAVPTVAWLCR	SNPH	431	O15079
LWDPNPKIGVACRDV	MROH2B	1441	Q7Z745
VNISVCQLDGTWEPP	SVEP1	3216	Q4LDE5
QAGCIPVLLSPRWEL	EXTL1	291	Q92935
ALRIPEGLWQLSPCQ	PLA2R1	1356	Q13018
VPNCADVRGTFPAAW	STRC	1461	Q7RTU9
RCPLEDPGWNAQITL	PHLDA3	86	Q9Y5J5
DVWVRIEDCPINNPR	APC	2656	P25054
ALVDTFCWIARAPPL	LINC01559	76	Q495D7
WIDPNLGCPSDAIEV	COL24A1	1561	Q17RW2
IAPGINRVDWPCFTR	TEPP	171	Q6URK8
GCRGAQVEEIWSLEP	UCHL5	26	Q9Y5K5
ANPTECWEIPVGRLN	THEMIS	496	Q8N1K5
VLNRPPGFLQVCDWL	SPART	261	Q8N0X7
ILEPNVTPGNCWAFE	SUN5	241	Q8TC36
TCWPATPRGQVVVLA	VIPR1	71	P32241
VEAFLQALPLCWVPG	TTC24	256	A2A3L6
QALPLCWVPGEQATV	TTC24	261	A2A3L6
PLDAVRAEWERTCGP	MRPL38	131	Q96DV4
TVQEWGPPAACRFSL	TMEM179	61	Q6ZVK1
CQWVVEDAPNPDVLL	NIBAN1	891	Q9BZQ8
QCWAPEDTIPLQDLV	TSEN34	261	Q9BSV6
CVPLSAWGEGQVEPL	PTGIR	346	P43119
DDLGPPRWQLTACLV	SLC6A3	231	Q01959
GLLQTPRWDEPQRVC	TBC1D16	276	Q8TBP0
SGLRCEPEPGRSQQW	TBC1D1	71	Q86TI0
TCRAEGNPKPEIIWL	PXDN	266	Q92626
ERKWAEAVVRPPGCS	TMEM79	171	Q9BSE2
GCSLWDDPARFIVVP	nan	46	Q7L0L9
WLRGVSPQSCSEDPA	TROAP	371	Q12815
WPALIECGVNLTQPL	STH	21	Q8IWL8
LPCDAGQGLTARIWE	SGSM1	581	Q2NKQ1
WTQVSGLQPLVEPCL	RPAP1	761	Q9BWH6
GVAWEDCPVVAELLG	SLC28A1	476	O00337
GFPECRSAVWLPDSV	TOP3A	681	Q13472
FLSPTSLREGECQWP	RET	126	P07949
CWRPANVGETVTVPC	VIPR2	61	P41587
SWCPDCVQAEPVVRE	TXNDC17	41	Q9BRA2
SPEEWGCLRPAQRAL	ZNF688	36	P0C7X2
EGVWPCAAPIAVSQL	WDR93	406	Q6P2C0
VRGQWTECSDFSPPI	ZDHHC7	201	Q9NXF8
LPWSECPVVRNGSVA	SLC6A17	176	Q9H1V8
CQLQPPVRGSREWAA	SH2D3C	496	Q8N5H7
FGVQQLPLEEIWPLC	PHGDH	186	O43175
LAVTPWVGDVVVPCT	SNAPC4	746	Q5SXM2
DRVCQQPGLSLWVPF	TAPR1	76	Q14CZ0
IPSSEEGWPIACQVL	TRMT12	311	Q53H54
CDSWLQGPLQEPAEA	PLEKHG2	691	Q9H7P9
CAQESVPLGPAVWVQ	PLEKHG2	886	Q9H7P9
EPQWCEVQGLVDERP	ULBP1	46	Q9BZM6
QGWEPCTDLRPLDIL	TSPEAR	21	Q8WU66
PKVISCLEQGEEPWV	ZNF75A	41	Q96N20
CLEQGEEPWVQVSPE	ZNF75A	46	Q96N20
PVTAVEFCPWRAGTL	WDR27	166	A2RRH5
QGDPDVPECLKVWDR	UBR4	771	Q5T4S7
VRPESWEPCVEVVPN	TLR4	21	O00206
PERFDTWPCILGLQS	TRIM58	326	Q8NG06
PAGALVALVVAPLCW	TYSND1	271	Q2T9J0
WYPVLGENTVPDRCC	TSPAN9	156	O75954
RDCAGPPVQVEWDRK	ZDHHC1	351	Q8WTX9
QGEEPWSVEQACPQR	ZNF606	116	Q8WXB4
CWKPDPDQVDGARSL	XKR8	346	Q9H6D3
CDVVGRPRPEITWEK	WFIKKN2	231	Q8TEU8
SCRPIIRPNSGFWEQ	DUSP18	136	Q8NEJ0
SPELSREPSQLWGCV	KLF6	151	Q99612
SESPNGRIATPLLCW	LDAH	171	Q9H6V9
PLPARIWLQLCGAQE	N4BP1	46	O75113
GEEWILNPTDCPVQR	MYO9A	71	B2RTY4
EEWVPANTEPVERCG	MYBPC2	781	Q14324
ITDPPRGCVGNTNIW	GRIN1	301	Q05586